Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Launched by UNIVERSITY OF CHICAGO · Aug 12, 2011

Keywords

ClinConnect Summary

This clinical trial is focused on collecting and storing tissue samples from patients who have been diagnosed with various types of gastrointestinal cancers, including gastric, esophageal, pancreas, liver, biliary, gastrointestinal stromal tumors, neuroendocrine tumors, peritoneal mesothelioma, anal, and colorectal cancers. The goal is to gather both normal and cancerous tissue, as well as blood samples, to create a valuable database. This information will help researchers study the biological features of these cancers, which can lead to better understanding and treatment options in the future.

To be eligible for this trial, participants must be diagnosed with one of the specified cancers and require surgery or a biopsy, which is a procedure to remove tissue for testing. If you decide to take part in this study, you can expect to provide tissue and blood samples during your medical procedure. Your samples will then be used for research to explore how certain proteins and genes may affect cancer development and treatment. This research is important for developing new therapies and improving care for patients with gastrointestinal cancers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • any patient diagnosed with Gastric (stomach) Cancer, Esophageal (foodpipe) Cancer, Pancreas Cancer, Liver Cancer, Biliary (gallbladder) Cancer, Gastrointestinal Stromal Tumor, Peritoneal Mesothelioma (cancer in the lining of the abdomen), Neuroendocrine (of or relating to the cells that release a hormone into the blood in response to a neural stimulus) Tumor, Anal Cancer or Colorectal Cancer cancer that requires you to undergo a surgical or diagnostic procedure.